Shinpoong Pharmaceutical Co Ltd
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial dru… Read more
Market Cap & Net Worth: Shinpoong Pharmaceutical Co Ltd (019175)
Shinpoong Pharmaceutical Co Ltd (KO:019175) has a market capitalization of $22.58 Million (₩33.05 Billion) as of March 18, 2026. Listed on the KO stock exchange, this Korea-based company holds position #11556 globally and #272 in its home market, demonstrating a 4.27% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shinpoong Pharmaceutical Co Ltd's stock price ₩16600.00 by its total outstanding shares 1991230 (1.99 Million).
Shinpoong Pharmaceutical Co Ltd Market Cap History: 2015 to 2026
Shinpoong Pharmaceutical Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $4.78 Million to $22.58 Million (15.56% CAGR).
Shinpoong Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shinpoong Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Shinpoong Pharmaceutical Co Ltd's market cap is 0.00 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $4.78 Million | $195.95 Billion | $1.48 Billion | 0.00x | 0.00x |
| 2016 | $5.48 Million | $194.15 Billion | -$18.59 Billion | 0.00x | N/A |
| 2017 | $6.36 Million | $185.00 Billion | $904.89 Million | 0.00x | 0.01x |
| 2018 | $7.99 Million | $187.39 Billion | $2.80 Billion | 0.00x | 0.00x |
| 2019 | $8.07 Million | $189.72 Billion | $5.32 Billion | 0.00x | 0.00x |
| 2020 | $166.11 Million | $197.75 Billion | $5.00 Billion | 0.00x | 0.03x |
| 2021 | $54.40 Million | $189.24 Billion | -$11.58 Billion | 0.00x | N/A |
| 2022 | $56.51 Million | $209.29 Billion | -$35.38 Billion | 0.00x | N/A |
| 2023 | $28.08 Million | $200.23 Billion | -$57.33 Billion | 0.00x | N/A |
| 2024 | $21.35 Million | $221.09 Billion | -$15.39 Billion | 0.00x | N/A |
Competitor Companies of 019175 by Market Capitalization
Companies near Shinpoong Pharmaceutical Co Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Shinpoong Pharmaceutical Co Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Shinpoong Pharmaceutical Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Shinpoong Pharmaceutical Co Ltd's market cap moved from $4.78 Million to $ 22.58 Million, with a yearly change of 15.56%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩22.58 Million | -29.36% |
| 2025 | ₩31.96 Million | +49.68% |
| 2024 | ₩21.35 Million | -23.97% |
| 2023 | ₩28.08 Million | -50.30% |
| 2022 | ₩56.51 Million | +3.88% |
| 2021 | ₩54.40 Million | -67.25% |
| 2020 | ₩166.11 Million | +1957.43% |
| 2019 | ₩8.07 Million | +1.02% |
| 2018 | ₩7.99 Million | +25.67% |
| 2017 | ₩6.36 Million | +16.07% |
| 2016 | ₩5.48 Million | +14.75% |
| 2015 | ₩4.78 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Shinpoong Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $22.58 Million USD |
| MoneyControl | $22.58 Million USD |
| MarketWatch | $22.58 Million USD |
| marketcap.company | $22.58 Million USD |
| Reuters | $22.58 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.